Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Invest Radiol. 2021 Jan;56(1):20–34. doi: 10.1097/RLI.0000000000000731

Figure 2.

Figure 2.

A) Intra-animal comparison of gadopiclenol enhanced (left) and gadobutrol-enhanced MR images of a rat glioma model showing the high relaxivity of gadopiclenol, which provides similar tumor enhancement at half the dose of gadobutrol (top) and much stronger enhancement at the same dose (bottom). B) Mn-PyC3A enhanced MR angiography in a baboon showing abdominal aorta and renal arteries compared to C) an equivalent dose of Gd-DTPA in the same animal. Adapted with permission from 28 and 25.